Medicare Benefits Schedule - Item 66833

Search Results for Item 66833



66833 - Additional Information

Item Start Date:
Description Updated:
Schedule Fee Updated:

P2 - Chemical

25-hydroxyvitamin D, quantification in serum, for the investigation of a patient who:

(a)    has signs or symptoms of osteoporosis or osteomalacia; or

(b)    has increased alkaline phosphatase and otherwise normal liver function tests; or

(c)    has hyperparathyroidism, hypo- or hypercalcaemia, or hypophosphataemia; or

(d)    is suffering from malabsorption (for example, because the patient has cystic fibrosis, short bowel syndrome,     inflammatory bowel disease or untreated coeliac disease, or has had bariatric surgery); or

(e)     has deeply pigmented skin, or chronic and severe lack of sun exposure for cultural, medical, occupational or     residential reasons; or

(f)    is taking medication known to decrease 25OH-D levels (for example, anticonvulsants); or

(g)    has chronic renal failure or is a renal transplant recipient; or

(h)    is less than 16 years of age and has signs or symptoms of rickets; or

(i)    is an infant whose mother has established vitamin D deficiency; or

(j)    is a exclusively breastfed baby and has at least one other risk factor mentioned in a paragraph in this item; or

(k)    has a sibling who is less than 16 years of age and has vitamin D deficiency

Fee: $30.05 Benefit: 75% = $22.55 85% = $25.55


  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change